Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis

Detalles Bibliográficos
Autor principal: Healthcare Engineering, Journal of
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432048/
https://www.ncbi.nlm.nih.gov/pubmed/37593493
http://dx.doi.org/10.1155/2023/9823939
_version_ 1785091314308612096
author Healthcare Engineering, Journal of
author_facet Healthcare Engineering, Journal of
author_sort Healthcare Engineering, Journal of
collection PubMed
description
format Online
Article
Text
id pubmed-10432048
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104320482023-08-17 Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-08-09 /pmc/articles/PMC10432048/ /pubmed/37593493 http://dx.doi.org/10.1155/2023/9823939 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Healthcare Engineering, Journal of
Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
title Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
title_full Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
title_fullStr Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
title_full_unstemmed Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
title_short Retracted: Targeting AraC-Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl-2: A Systematic Review and Meta-Analysis
title_sort retracted: targeting arac-resistant acute myeloid leukemia by dual inhibition of cdk9 and bcl-2: a systematic review and meta-analysis
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432048/
https://www.ncbi.nlm.nih.gov/pubmed/37593493
http://dx.doi.org/10.1155/2023/9823939
work_keys_str_mv AT healthcareengineeringjournalof retractedtargetingaracresistantacutemyeloidleukemiabydualinhibitionofcdk9andbcl2asystematicreviewandmetaanalysis

Ejemplares similares